The report "Varicose
Vein Treatment Market in North America and Europe by Treatment Mode
(Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF
Ablation, Venous Closure, Surgical) - Forecasts to 2021",
The varicose vein treatment market in North America and Europe is expected to
reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of
6.9% between 2016 and 2021.
Full Report @ http://www.marketsandmarkets.com/Market-Reports/varicose-vein-treatment-market-22524107.html
The report provides a detailed overview of the major
drivers, restraints, opportunities, and challenges impacting the varicose vein
treatment market in North America and Europe along with the estimates and
forecasts of the revenue and market share analysis.
The varicose vein treatment market is poised to witness a
steady growth between 2016 and 2021. Shift towards less-invasive treatment
procedures, availability of advanced varicose vein treatment devices, huge
burden of varicose vein cases in North America and Europe, improving patient
compliance & reliability, growing healthcare expenditure, and rapid growth
in aging population will majorly drive the varicose vein treatment market.
Download PDF Brochure
@ http://www.marketsandmarkets.com/pdfdownload.asp?id=22524107
This report broadly segments the varicose vein treatment
market into mode of treatment and products. The varicose vein treatment market,
by products is segmented into ablation devices, venous closure products, and surgical
products. The ablation devices segment is further categorized into
radiofrequency ablation devices and laser ablation devices. On the basis of
mode of treatment, the varicose vein treatment market is segmented into
endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.
This report covers the varicose vein treatment market across
two major geographies, namely, North America and Europe. In this report, the
North American varicose vein treatment market is further segmented into the
U.S. and Canada, while the European varicose vein treatment market is
categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In
2016, North America is expected to command the largest share of the varicose
vein treatment market in North America and Europe. However, Europe is expected
to register the highest growth rate during the forecast period from 2016 to
2021, due to increasing adoption of advanced treatment procedures and favorable
government initiatives in this region.
Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.);
biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel);
Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy);
Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc.
(U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.)
are the key players in the varicose vein treatment market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 5000 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of incremental
revenues for both the company and its competitors. MarketsandMarkets™ now
coming up with 1,500 MicroQuadrants (Positioning top players across leaders,
emerging companies, innovators, strategic players) annually in high growth
emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000
companies this year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of the unmet insights along with
market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
No comments:
Post a Comment